Mariam Baig, MD (@mariambaigmd) 's Twitter Profile
Mariam Baig, MD

@mariambaigmd

Advanced Cardiac Imaging/Cardio-Oncology Fellow @YaleCardiology || @SLUCards||@UMKCmedschool || #Multimodality Imaging

ID: 1561508438303293440

calendar_today22-08-2022 00:20:08

42 Tweet

189 Followers

205 Following

Debapria Das, MD (@priexcitation) 's Twitter Profile Photo

The best thing about SLU Cardiology Fellowship was going through it with Mariam Baig, MD, Sam Atallah, MD, and Niteesh Chitturu. Love you guys. I'm proud I was able to be your co-fellow and now your #cardiology colleague. Thank you Ammar Nasir and Deana Mikhalkova for bringing us together 🫀

The best thing about <a href="/SLUCards/">SLU Cardiology Fellowship</a> was going through it with <a href="/MariamBaigMD/">Mariam Baig, MD</a>, <a href="/SamTheUncle7/">Sam Atallah, MD</a>, and <a href="/ChitturuNiteesh/">Niteesh Chitturu</a>. Love you guys. I'm proud I was able to be your co-fellow and now your #cardiology colleague. Thank you <a href="/AmmarNasirMD/">Ammar Nasir</a> and <a href="/MikhalkovaDeana/">Deana Mikhalkova</a> for bringing us together 🫀
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Read the new #JACCIMG international position statement on multimodality #cvImaging for #pericardial disease evaluation & treatment (pericarditis, effusion, constriction, & masses). bit.ly/3WSxAvm #Echofirst #YesCCT #whyCMR

Read the new #JACCIMG international position statement on multimodality #cvImaging for #pericardial disease evaluation &amp; treatment (pericarditis, effusion, constriction, &amp; masses). bit.ly/3WSxAvm

#Echofirst #YesCCT #whyCMR
Ibolya Csecs MD PhD (@ibolya_csecs) 's Twitter Profile Photo

Proud to represent Yale Cardiology in the 🌟Early Career Award section at #SCMR2025! Excited to share our results on 🧲CMR characteristics of ~700 patients with Autoimmune Rheumatic Diseases #CardioRheum Thankful for mentorship🙏🏼 Attila Feher, MD, PhD Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR Edward Miller, MD PhD

Proud to represent <a href="/YaleCardiology/">Yale Cardiology</a> in the 🌟Early Career Award section at #SCMR2025!

Excited to share our results on 🧲CMR characteristics of ~700 patients with Autoimmune Rheumatic Diseases #CardioRheum 

Thankful for mentorship🙏🏼
<a href="/attilafehermd/">Attila Feher, MD, PhD</a> <a href="/CardioOnc_MR_CT/">Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR</a> <a href="/edwardmillermd/">Edward Miller, MD PhD</a>
Sara Ersözlü, MD (@ersozlusara) 's Twitter Profile Photo

🚨 Late-Breaking Clinical Trial Alert! 🚨 #SCMR2025 #whyCMR Strong association between stress CMR ischemia burden and cardiovascular events in the ISCHEMIA Trial! 🫀 🧲 Post-hoc analysis confirms the prognostic power of CMR in risk stratification. Presented by Raymond Y.

🚨 Late-Breaking Clinical Trial Alert! 🚨 #SCMR2025 #whyCMR

Strong association between stress CMR ischemia burden and cardiovascular events in the ISCHEMIA Trial!  🫀 🧲 

Post-hoc analysis confirms the prognostic power of CMR in risk stratification.

Presented by Raymond Y.
Ritu Thamman MD (@iamritu) 's Twitter Profile Photo

Braunwald reverses 35 year old stance in asymptomatic severe aortic stenosis &AVR bit.ly/3EBr0Tt Don’t wait for symptoms to develop in severe AS! No more “watchful waiting” #justdoit Act & send patient for TAVR or SAVR JAMA Cardiology

Braunwald reverses 35 year old stance in asymptomatic severe aortic stenosis &amp;AVR
bit.ly/3EBr0Tt

Don’t wait for symptoms to develop in severe AS! 

No more “watchful waiting”
#justdoit Act &amp; send patient for TAVR or SAVR <a href="/JAMACardio/">JAMA Cardiology</a>
Journal of Nuclear Cardiology (@jncjournal) 's Twitter Profile Photo

Serial PET for clinical indications shows MFR doesn't change much over time but increases post-revascularization. Serial MFR & perfusion assessments improve CV risk prediction. Read now👉bit.ly/4iHSar5 Attila Feher, MD, PhD #cvnuc Edward Miller, MD PhD Ilias Nikolakopoulos Ibolya Csecs MD PhD

Serial PET for clinical indications shows MFR doesn't change much over time but increases post-revascularization. Serial MFR &amp; perfusion assessments improve CV risk prediction.

Read now👉bit.ly/4iHSar5
<a href="/attilafehermd/">Attila Feher, MD, PhD</a> #cvnuc <a href="/edwardmillermd/">Edward Miller, MD PhD</a> <a href="/INikolakopoulos/">Ilias Nikolakopoulos</a> <a href="/ibolya_csecs/">Ibolya Csecs MD PhD</a>
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) (ALPACA trial) nej.md/4kWjJyn Editorial: Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease nej.md/44cSNVe #Cardiology

Original Article: Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) (ALPACA trial) nej.md/4kWjJyn 

Editorial: Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease nej.md/44cSNVe 

#Cardiology
American Society of Echocardiography (@ase360) 's Twitter Profile Photo

🫀NEW GUIDELINE🫀 Read our newest #ASEGuideline, "Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis!" bit.ly/3Gyh2n4

🫀NEW GUIDELINE🫀
Read our newest #ASEGuideline, "Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis!" bit.ly/3Gyh2n4